Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor α-dependent manner

Cancer Research

Volumn 68, Issue 1, 2008, Pages 106-114

  Bretschneider, Nancy ^a   Brand, Heike ^a   Miller, Nicola ^b   Lowery, Aoife J ^b   Kerin, Michael J ^b   Gannon, Frank ^a   Denger, Stefanie ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; BASE PROTEIN, HUMAN; FOXA1 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASE GENE; BINDING SITE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE REPRESSION; GENETIC REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; BREAST TUMOR; DOWN REGULATION; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; TUMOR CELL LINE;

BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; ENHANCER ELEMENTS (GENETICS); ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MEMBRANE PROTEINS; MUTATION; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); TUMOR MARKERS, BIOLOGICAL;

EID: 39149132132     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5647     Document Type: Article

References (30)

1. Murphy N, Millar E, Lee CS. Gene expression profiling in breast cancer: towards individualising patient management. Pathology 2005;4:271-7.
2. Egland KA, Vincent JJ, Strausberg R, Lee B, Pastan I. Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins. Proc Natl Acad Sci U S A 2003;3:1099-104.
3. Beeley JG, Eason R, Snow DH. Isolation and characterization of latherin, a surface-active protein from horse sweat. Biochem J 1986;3:645-50.
4. Bingle CD, Craven CJ. Meet the relatives: a family of BPI- and LBP-related proteins. Trends Immunol 2004;2:53-5.
5. Mader S, Kumar V, de Verneuil H, Chambon P. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 1989;6212:271-4.
6. Reid G, Hubner MR, Metivier R, et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 2003;3:695-707.
7. Cartharius K, Frech K, Grote K, et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005;13:2933-42.
8. Denger S, Reid G, Kos M, et al. ERα gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol 2001;12:2064-77.
9. Metivier R, Penot G, Hubner, MR, et al. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003;6:751-63.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 2001;4:402-8.
11. Dao TN, Lamont JP, Knox SM. Clinical utility of breast magnetic resonance imaging in patients presenting with primary breast cancer. Proc (Bayl Univ Med Cent) 2007;3:227-30.
12. American Cancer Society. Breast cancer facts and figures 2005-2006. Atlanta: American Cancer Society, Inc.
13. Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 2002;2:279-89.
14. Doane AS, Danso M, Lal P, et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 2006;28:3994-4008.
15. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;6871:530-6.
16. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 1999;16:9212-7.
17. Carroll JS, Liu XS, Brodsky AS, et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005;1:33-43.
18. Carrol JS, Meyer CA, Song J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006;11:1289-97.
19. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V. From the Cover: Location analysis of estrogen receptor α target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A 2005;33:11651-6.
20. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003;10:4562-74.
21. Liu WD, Wang HW, Muguira M, Breslin MB, Lan MS. INSM1 functions as a transcriptional repressor of the neuroD/β2 gene through the recruitment of cyclin D1 and histone deacetylases. Biochem J 2006;1:169-77.
22. Gillett C, Smith P, Gregory W, et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer 1996;2:92-9.
23. Pedersen N, Pedersen MW, Lan MS, Breslin MB, Poulsen HS. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer. Cancer Gene Ther 2006;4:375-84.
24. Taniwaki M, Daigo Y, Ishikawa N, et al. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol 2006;3:567-75.
25. Nicolini A, Carpi A, Tarro G. Biomolecular markers of breast cancer. Front Biosci 2006;11:1818-43.
26. Nakshatri H, Badve S. FOXA1 as a therapeutic target for breast cancer. Expert Opin Ther Targets 2007;4:507-14.
27. In der Maur CD, Klokman WJ, van Leeuwen FE, Tan IB, Rutgers EJ, Balm AJ. Increased risk of breast cancer development after diagnosis of salivary gland tumour. Eur J Cancer 2005;9:1311-5.
28. Berg JW, Hutter RV, Foote FW, Jr. The unique association between salivary gland cancer and breast cancer. JAMA 1968;9:771-4.
29. Moertel CG, Elveback LR. The association between salivary gland cancer and breast cancer. JAMA 1969;2:306-8.
30. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 2006;4:1033-67.